DMAC
NASDAQ · Biotechnology
Diamedica Therapeutics Inc
$10.77
+0.77 (+7.70%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-61.4% upside
Low Target
$2.49
Average Target
$4.16
High Target
$4.48
Current Price
$10.77
Current
$10.77
$10.77
Target
$4.16
$4.16
$2.49
$4.16 avg
$4.48
Scenario Analysis
Bear Case
$2.49
-76.9%
Low target
Base Case
$4.16
-61.4%
Avg target
Bull Case
$4.48
+-58.4%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$11.00
-2.1% from high
52-Week Low
$5.25
+105.3% from low
Target vs 52W High
$4.16
-62.2% vs high
Next Earnings Report
Nov 18, 2026 · After Market Close
10d
until earnings
EPS Est: $-0.21
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |